Mowat-Wilson syndrome: Neurological and molecular study in seven patients;Síndrome de Mowat-Wilson: Estudo neurológico e molecular em sete pacientes

Arquivos de Neuro-Psiquiatria

Volumn 73, Issue 1, 2015, Pages 12-17

  da Paz, José Albino ^a   Kim, Chong Ae ^a   Goossens, Michael ^b   Giurgea, Irina ^b   Marques Dias, Maria Joaquina ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Corpus callosum agenesis; Epilepsy; Mental retardation; Microcephaly; Mowat Wilson syndrome

Indexed keywords

ADOLESCENT; ARTICLE; ASSESSMENT OF HUMANS; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORPUS CALLOSUM AGENESIS; DENVER II SCALE; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAM; FEMALE; FOCAL EPILEPSY; GENE; GENE MUTATION; GENETIC ANALYSIS; GLIOSIS; HUMAN; HYPERSALIVATION; LANGUAGE DISABILITY; MALE; MENTAL DEFICIENCY; MICROCEPHALY; MOWAT WILSON SYNDROME; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; WALKING DIFFICULTY; ZEB2 GENE; FACIES; GENETICS; HIRSCHSPRUNG DISEASE; INFANT; INTELLECTUAL IMPAIRMENT; MUTATION; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

HOMEODOMAIN PROTEIN; REPRESSOR PROTEIN; ZEB2 PROTEIN, HUMAN;

CHILD; CHILD, PRESCHOOL; FACIES; FEMALE; HIRSCHSPRUNG DISEASE; HOMEODOMAIN PROTEINS; HUMANS; INFANT; INTELLECTUAL DISABILITY; MALE; MICROCEPHALY; MUTATION; REPRESSOR PROTEINS; RETROSPECTIVE STUDIES;

EID: 84921785422     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/0004-282X20140182     Document Type: Article

References (20)

1. Mowat DR, Croaker GD, Cass DT, et al. Hirschsprung disease, microcephaly, mental retardation, and characteristic facial features: delineation of a new syndrome and identification of a locus at chromosome 2q22-q23. J Med Genet. 1998;35:617-23.
2. Mowat D, Wilson M. Mowat-Wilson syndrome. In: Cassidy SB, Allanson JE, editors. Management of genetic syndromes. 3rd ed. New Jersey: John Wiley and Sons; 2010.
3. Cacheux V, Dastot-Le Moal F, Kääriäinen H, et al. Loss of function mutations in SIP1 Smad interacting protein 1 result in a syndromic Hirschsprung disease. Hum Mol Genet. 2001;10:1503-10.
4. Wakamatsu N, Yamada Y, Yamada K, et al. Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease. Nat Genet. 2001;27:369-370.
5. Watanabe M, Whitman M. FAST-1 is a key maternal effector of mesoderm inducers in the early Xenopus embryo. Development. 1999;126:5621-5634.
6. Shi Y. Structural insights on Smad function in TGFbeta signaling. Bioessays. 2000;23:223-232.
7. Espinosa-Parrilla Y, Amiel J, Augé J, et al. Expression of the SMADIP1 gene during early human development. Mech Dev. 2002;114:187-191.
8. McGaughran J, Sinnott S, Dastot-Le Moal F, et al. Recurrence of Mowat-Wilson syndrome in siblings with the same proven mutation. Am J Med Genet. 2005;137:302-304.
9. Zweier C, Thiel CT, Dufke A, et al. Clinical and mutational spectrum of Mowat-Wilson syndrome. Eur J Med Genet. 2005;48:97-111.
10. Ohtsuka M, Oguni H, Ito Y, et al. Mowat-Wilson syndrome affecting 3 siblings. J Child Neurol. 2008;23:274-278.
11. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;5:676-685.
12. Frankenburg WK, Dodds JB, Archer P, et al. The Denver II: a major revision and restandardization of Denver Developmental Screening Test. Pediatrics. 1992;89:91-97.
13. Dastot-Le Moal F, Wilson M, Mowat D, et al. ZFHX1B mutations in patients with Mowat-Wilson Syndrome. Hum Mutat. 2007;28:313-321.
14. Mowat DR, Wilson MJ, Goossens M. Mowat-Wilson syndrome. J Med Genet. 2003;40:305-310.
15. Adam MP, Schelley S, Gallagher R, et al. Clinical features and management issues in Mowat-Wilson syndrome. Am J Med Genet. 2006;140:2730-2741.
16. Ishihara N, Yamada K, Yamada Y, et al. Clinical and molecular analysis of Mowat-Wilson syndrome associated with ZFHX1B mutations and deletions at 2q22-q24.1. J Med Genet. 2004;4:387-393.
17. Wilson M, Mowat D, Dastot-Le Moal F, et al. Further delineation of the phenotype associated with heterozygous mutations in ZFHX1B. Am J Med Genet. 2003;119:257-265.
18. Garavelli L, Zollino M, Mainardi PC, et al. Mowat-Wilson syndrome: facial phenotype changing with age, study of 19 Italian patients and review of the literature. Am J Med Genet 2009;149:417-426.
19. Cordelli DM, Garavelli L, Savasta S, et al. Epilepsy in Mowat-Wilson syndrome: delineation of the electroclinical phenotype. Am J Med Gene. 2013;161:273-284.
20. Valera ET, Ferraz ST, Brassesco MS, et al. Mowat-Wilson syndrome: the first report of an association with central nervous system tumors Childs Nerv Syst. 2013;29:2151-2155.